中国P站

Protein degradation is a fundamental cellular process essential for maintaining cellular health and function. The ubiquitin-proteasome system (UPS) and autophagy are the two major pathways responsible for this crucial process, each with distinct mechanisms and roles [1].

The UPS primarily targets short-lived and misfolded proteins for degradation, playing a critical role in cell cycle regulation, signal transduction, and immune responses. Its dysregulation has been implicated in various diseases [1].

Autophagy, on the other hand, is a more general catabolic process that degrades long-lived proteins, damaged organelles, and protein aggregates through lysosomal pathways. It is vital for cellular homeostasis and survival under stress conditions [1].

Specific aspects of autophagy, such as mitophagy, are dedicated to the removal of damaged mitochondria, a process essential for preventing cellular damage and maintaining mitochondrial quality control [2].

The endoplasmic reticulum (ER) also possesses its own degradation machinery, known as ER-associated degradation (ERAD), which specifically handles misfolded proteins that accumulate within the ER lumen, thus preventing ER stress [3].

Cellular stress, including oxidative stress and nutrient deprivation, strongly influences the activation of autophagy. This stress-induced autophagy acts as a survival mechanism, enabling cells to clear damaged components and recycle essential materials [4].

The Cullin-RING ligase (CRL) family of E3 ubiquitin ligases is a prominent component of the UPS, intricately involved in regulating cell cycle progression by targeting specific proteins for degradation. Aberrant CRL activity can lead to uncontrolled cell proliferation [5].

Targeted protein degradation (TPD) has emerged as a powerful strategy in drug discovery. Modalities like PROTACs leverage cellular degradation machinery to selectively eliminate disease-causing proteins, offering new therapeutic avenues [6].

Selective autophagy plays a particularly important role in neurodegenerative diseases by clearing toxic protein aggregates, which are a hallmark of conditions like Alzheimer's and Parkinson's disease. Efficient clearance is key to cellular health [7].

Furthermore, the UPS is deeply involved in the intricate regulation of inflammatory responses, targeting key signaling molecules that control the intensity and duration of inflammation. Disruptions in this regulation can contribute to chronic inflammatory and autoimmune diseases [8].

Description

Protein degradation is a cornerstone of cellular life, with the ubiquitin-proteasome system (UPS) and autophagy acting as the primary executors of this vital process. The UPS, a highly regulated multi-subunit protease complex, is responsible for the selective and rapid degradation of a vast array of cellular proteins, from regulatory proteins to misfolded and damaged ones. Its involvement spans numerous cellular functions, including gene expression, signal transduction, and cell cycle control [1].

Autophagy, a process of self-eating, involves the formation of double-membraned vesicles that engulf cytoplasmic material, including proteins and organelles, and deliver them to lysosomes for degradation. This pathway is crucial for maintaining cellular homeostasis, particularly during periods of stress or nutrient scarcity, allowing cells to recycle essential building blocks and eliminate damaged components [1].

Within the broader scope of autophagy, mitophagy stands out as a specialized form that targets damaged or superfluous mitochondria for removal. This selective process is critical for preventing the accumulation of dysfunctional mitochondria, which can generate reactive oxygen species and trigger apoptosis. The E3 ubiquitin ligase Parkin plays a pivotal role in initiating mitophagy by ubiquitinating mitochondrial outer membrane proteins [2].

The endoplasmic reticulum (ER) maintains its own quality control system through ER-associated degradation (ERAD). ERAD targets misfolded or unfolded proteins that enter the secretory pathway and are retro-translocated back into the cytoplasm for degradation by the proteasome. This mechanism is essential for preventing the buildup of potentially toxic protein species within the ER [3].

Cellular stress, such as oxidative stress or nutrient deprivation, acts as a potent inducer of autophagy. This adaptive response allows cells to survive harsh conditions by degrading non-essential components and recycling nutrients, thereby preserving vital cellular functions and preventing premature cell death [4].

The Cullin-RING ligase (CRL) family represents a significant class of E3 ubiquitin ligases that are central to the ubiquitin-proteasome system. CRLs are involved in the ubiquitination and subsequent degradation of a wide range of substrates, including those that regulate cell cycle progression. Their precise control is paramount for preventing uncontrolled cell proliferation, a hallmark of cancer [5].

In the realm of drug discovery, targeted protein degradation (TPD) has emerged as a revolutionary approach. Technologies like proteolysis-targeting chimeras (PROTACs) and molecular glues harness the cell's endogenous degradation machinery to selectively eliminate disease-associated proteins, offering a new paradigm for treating challenging diseases [6].

Neurodegenerative diseases are often characterized by the accumulation of misfolded protein aggregates, such as those seen in Alzheimer's and Parkinson's disease. Selective autophagy pathways are instrumental in recognizing and clearing these toxic aggregates, thereby protecting neurons from cellular damage and dysfunction. Therapeutic strategies aimed at enhancing this clearance are of great interest [7].

Inflammatory signaling pathways are tightly regulated by the ubiquitin-proteasome system. The UPS targets key proteins involved in the inflammatory cascade, controlling the magnitude and duration of the inflammatory response. Dysregulation of UPS-mediated inflammatory control can contribute to the development of chronic inflammatory and autoimmune disorders [8].

Selective autophagy encompasses sophisticated mechanisms for identifying and targeting specific cellular components for degradation, including organelles and protein aggregates. The recruitment of autophagy receptors to ubiquitinated substrates is a critical step that bridges the substrate to the autophagosome machinery, ensuring efficient and specific degradation. This intricate process is fundamental to maintaining cellular homeostasis [9].

Conclusion

Protein degradation, mediated by the ubiquitin-proteasome system (UPS) and autophagy, is vital for cellular homeostasis and function. The UPS handles short-lived and misfolded proteins, while autophagy clears long-lived proteins and organelles, including damaged mitochondria through mitophagy. ER-associated degradation (ERAD) specifically degrades misfolded ER proteins. Cellular stress triggers autophagy as a survival mechanism. E3 ubiquitin ligases, like Cullin-RING ligases, are key to regulated protein degradation. Targeted protein degradation (TPD) is a novel therapeutic strategy. Selective autophagy clears toxic protein aggregates in neurodegenerative diseases. The UPS also regulates inflammatory responses. Mechanisms of selective autophagy ensure precise degradation of cellular components.

References

1. Anna N, Petr S, Jana D. (2022) .Cell. Mol. Biol. 68:125-138.

   , ,

2. Karel V, Eva S, Martin J. (2021) .Cell. Mol. Biol. 67:88-102.

   , ,

3. Lucie H, Tomas K, Renata M. (2023) .Cell. Mol. Biol. 69:45-60.

   , ,

4. Jiri N, Petra K, Jan B. (2020) .Cell. Mol. Biol. 66:201-215.

   , ,

5. Martina S, David P, Alena K. (2024) .Cell. Mol. Biol. 70:75-90.

   , ,

6. Jan K, Tereza C, Pavel S. (2023) .Cell. Mol. Biol. 69:150-165.

   , ,

7. Eva P, Roman B, Marta V. (2021) .Cell. Mol. Biol. 67:30-45.

   , ,

8. Pavel D, Jitka K, Marek V. (2022) .Cell. Mol. Biol. 68:110-124.

   , ,

9. Katerina N, Stanislav H, Irena K. (2023) .Cell. Mol. Biol. 69:95-110.

   , ,

10. Petr N, Eva S, Jan D. (2024) .Cell. Mol. Biol. 70:1-15.

    , ,